These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2679691)

  • 1. Imipenem and aztreonam: current role in antimicrobial therapy.
    Rice LB; Eliopoulos GM
    Curr Clin Top Infect Dis; 1989; 10():109-39. PubMed ID: 2679691
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
    Sánchez C; Garau J
    Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():67-75. PubMed ID: 2490491
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The newer cephalosporins. Aztreonam and imipenem.
    Ennis DM; Cobbs CG
    Infect Dis Clin North Am; 1995 Sep; 9(3):687-713. PubMed ID: 7490439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symposium on antimicrobial therapy. V. The carbapenems and monobactams.
    Greenfield RA
    J Okla State Med Assoc; 1993 Feb; 86(2):63-5. PubMed ID: 8331460
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenems, monobactams and quinolones.
    Chambers ST
    N Z Med J; 1989 Jan; 102(860):6-7. PubMed ID: 2536477
    [No Abstract]   [Full Text] [Related]  

  • 7. [New beta-lactam antibiotics: penems and monobactams].
    Swierzy H
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1687-90. PubMed ID: 3268823
    [No Abstract]   [Full Text] [Related]  

  • 8. Aztreonam: an appraisal.
    Neu HC
    N J Med; 1986 Jan; Spec No():42-5. PubMed ID: 3485269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Third generation cephalosporins, monobactams and carbapenems].
    Perronne C; Vildé JL
    Rev Prat; 1988 Mar; 38(8):469-76. PubMed ID: 3163818
    [No Abstract]   [Full Text] [Related]  

  • 10. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of ciprofloxacin in comparison with aztreonam, imipenem, and ceftazidime against multiply resistant strains.
    Nemes G; Stolle D; Nemes P
    Chemioterapia; 1987 Jun; 6(2 Suppl):133-5. PubMed ID: 3334552
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of monobactam antibiotics in surgical infections.
    DiPiro JT; Bowden TA
    Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem in the treatment of post-traumatic osteitis.
    Ketterl R; Beckurts T; Stübinger B; Claudi B
    Chemioterapia; 1987 Jun; 6(2 Suppl):435-6. PubMed ID: 3509467
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo experience with carumonam: a preliminary report.
    Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
    J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
    [No Abstract]   [Full Text] [Related]  

  • 15. Aztreonam: the first monobactam antibiotic.
    Stutman HR
    Pediatr Infect Dis J; 1987 Jun; 6(6):550-5. PubMed ID: 3302907
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 17. Gram-negative aerobic bacterial infections: a focus on directed therapy, with special reference to aztreonam.
    Rev Infect Dis; 1985; 7 Suppl 4():S537-843. PubMed ID: 4081472
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
    Tirone F; Musca G; Filomia D; Vigna L
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
    Raz R; Flatau E; Sudarsky M; Keness J
    Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential resistance of hospital Pseudomonas aeruginosa to ceftazidime, imipenem or aztreonam.
    Krcméry V; Antal M; Menkyna R; Knothe H; Schäfer V
    J Chemother; 1989 Jul; 1(4 Suppl):364-5. PubMed ID: 16312441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.